The Future of Health: A New World of Collaboration
Michael Milken, Francis Collins, Lynn Goldman, Bob Hugin
The National Institutes of Health, alongside corporate leaders like Celgene and academic institutions such as GW School of Public Health, is driving a decade-long strategic shift toward cross-sector collaboration to address mounting global health crises including opioid addiction, rising obesity-related cancers, and antimicrobial resistance. Key initiatives such as the Accelerating Medicines Partnership and the "All of Us" research program are deploying hundreds of millions in combined public and private funding to accelerate therapeutic discovery, leverage genomic data, and implement preventive structural interventions. This coordinated effort aims to reverse declining U.S. life expectancy trends and reduce the $4 trillion annual economic burden of chronic disease by aligning industry innovation cycles with public health objectives.